# Abvc Biopharma, Inc.: Form 8-K/A, filed Jan 16, 2026

- Company: [Abvc Biopharma, Inc.](/companies/abvc.md) (CIK 1173313)
- Form: 8-K/A
- Filed: 2026-01-16
- Accepted by EDGAR: Jan 16, 2026, 16:30 ET
- Period: 2025-04-30
- Accession: 0001213900-26-005165
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/ea0272768-8ka1_abvc.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1173313/000121390026005165/ea0272768-8ka1_abvc.htm

Filed Jan 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-005165. Last ingested by Listed: Nov 2, 2026, 09:52 ET. No prices; not investment advice.